| Press Release - | Contraceptive Drugs Market to Reach Valuation of USD 16.5 Billion by 2028 – Increasing Awareness About Birth Control Drives the Market |
Vantage Market Research | 22 Jun 2022
Healthcare
Contraceptive Drugs Market to Reach Valuation of USD 16.5 Billion by 2028 – Increasing Awareness About Birth Control Drives the Market

In terms of revenue, the Global Contraceptive Drugs Market is expected to reach USD 16.5 Billion by 2028, growing at a Compound Annual Growth Rate (CAGR) of 5.4% from 2022 to 2028.
The increasing awareness about birth control, government initiatives, and increased use of oral pills are anticipated to augment the growth of the market during the forecast period.
Key Highlights from Report:
Market Dynamics:
Contraception is a method of controlling the birth rate and unwanted pregnancy and also reducing the risk of diseases like STD which stands for sexually transmitted disease. Contraception drugs are taken orally this drug are used by women who avoid unwanted pregnancy. this drug is not only used for birth control but also for reducing the risk of sexually transmitted diseases. Government activity like launching new Contraceptive Drugs Market, at low cost will support market growth. Rising awareness about family planning and the use of birth control pills has increased over the past few years. During the lockdown, this market growth was hampered as women were unable to purchase pills or visit a healthcare center.
North America held the largest shares in 2021. The U.S. held the largest share in North America for the Contraceptive Drugs Market. Awareness about birth control pills in this region and the adoption of Contraceptive Drugs Market drive the market growth in this region.
About Vantage Market Research:
We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.
Healthcare
Contraceptive Drugs Market to Reach Valuation of USD 16.5 Billion by 2028 – Increasing Awareness About Birth Control Drives the Market
22 Jun 2022
Min Read
Access Full Report
Contraceptive Drugs Market to Reach Valuation of USD 16.5 Billion by 2028 – Increasing Awareness About Birth Control Drives the Market
This report by Vantage Market Research delivers comprehensive analysis of Somatostatin Analogs Market , focusing on Market Size, Share & Trends Analysis Report by Type (Octreotide, Lanreotide, Pasireotide) by Application (Acromegaly, Neuroendocrine Tumors (NETs), Others) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
Request SampleRelated Reports
Latest Press Release
Contact
Toll Free Number+1 (877) 462-2282